Prestigious Award Recognizes Groundbreaking Body's Defenses Research

The Nobel Prize in medical science was granted for revolutionary findings that illuminate how the immune system targets harmful infections while protecting the body's own cells.

Three esteemed researchers—from Japan Prof. Sakaguchi and US experts Mary Brunkow and Dr. Ramsdell—received this accolade.

Their work uncovered specialized "sentinels" within the defense system that eliminate rogue immune cells capable of attacking the body.

The findings are now paving the way for new therapies for immune disorders and malignancies.

The winners will divide a monetary award valued at 11 million Swedish kronor.

Decisive Findings

"Their work has been decisive for comprehending how the body's defenses functions and why we do not all suffer from serious self-attack conditions," commented the chair of the award panel.

The trio's studies explain a fundamental question: How does the defense system protect us from numerous infections while keeping our healthy cells unharmed?

The body's protection system uses immune cells that scan for indicators of infection, including pathogens and germs it has never encountered.

Such defenders employ sensors—known as recognition units—that are generated by chance in a vast number of variations.

That provides the immune system the ability to fight a broad range of threats, but the unpredictability of the process inevitably creates white blood cells that can attack the host.

Protectors of the Immune System

Scientists previously knew that a portion of these problematic defense cells were destroyed in the immune organ—the site where immune cells mature.

The latest Nobel Prize honors the discovery of regulatory T-cells—known as the body's "security guards"—which patrol the body to disarm any defenders that attack the body's own tissues.

We know that this mechanism fails in autoimmune diseases such as type-1 diabetes, MS, and RA.

The Nobel panel added, "These findings have laid the foundation for a novel area of research and spurred the creation of new therapies, for instance for tumors and autoimmune diseases."

Regarding cancer, regulatory T-cells block the system from fighting the growth, so research are aimed at reducing their quantity.

For self-attack disorders, trials are testing increasing T-reg cells so the body is no longer under attack. A similar approach could also be useful in minimizing the chances of transplanted organ failure.

Pioneering Experiments

Prof Sakaguchi, from a Japanese institution, performed tests on rodents that had their immune gland removed, causing self-attack conditions.

The researcher showed that injecting defense cells from other mice could stop the disease—implying there was a system for preventing immune cells from harming the host.

Dr. Brunkow, affiliated with the Institute for Systems Biology in Seattle, and Fred Ramsdell, currently at Sonoma Biotherapeutics in San Francisco, were investigating an inherited autoimmune disease in mice and humans that led to the identification of a genetic factor vital for the way regulatory T-cells function.

"The pioneering research has uncovered how the body's defenses is kept in check by regulatory T cells, preventing it from accidentally attacking the body's own tissues," commented a leading physiology expert.

"This work is a remarkable illustration of how basic physiological research can have far-reaching consequences for human health."